Assessing LncRNA DQ786243 and IL-17 Expression in Oral Lichen Planus: A Case Control Study

NCT04503824 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2020-08-07

No results posted yet for this study

Summary

Observational case-control study. The current study aims to assess the salivary expression of lncRNA DQ786243 and IL-17 in OLP, to better understand the pathogenesis of OLP and provide effective targets for OLP therapy.

Conditions

  • Patients With Oral Lichen Planus

Interventions

DIAGNOSTIC_TEST

saliva samples

Salivary expression of lncRNA DQ786243 and IL-17 will be evaluated using qRT-PCR.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-05
Primary Completion
2021-06-29
Completion
2021-07-29

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04503824 on ClinicalTrials.gov